ZS Pharma, Inc. et al v. Ascent Pharmaceuticals Inc. et al

DocketSO ORDERED, re #18 STIPULATION TO EXTEND TIME to Respond to complaint to November 2, 2022 filed by Ascent Pharmaceuticals Inc. Signed by Judge Gregory B. Williams on 10/19/22. (ntl) (Entered: 10/19/2022)

DocketSO ORDERED, re (20 in 1:22-cv-01100-GBW, 19 in 1:22-cv-01096-GBW, 17 in 1:22-cv-01099-GBW, 20 in 1:22-cv-01055-GBW, 20 in 1:22-cv-01101-GBW) STIPULATION and [Proposed] Order Regarding Case Coordination and Extension of Deadline for Case Schedule filed by AstraZeneca Pharmaecuticals LP, AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc. Signed by Judge Gregory B. Williams on 10/18/22. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW (ntl) (Entered: 10/19/2022)

Docket(#18) STIPULATION TO EXTEND TIME to Respond to complaint to November 2, 2022 - filed by Ascent Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 10/18/2022)

Docket(#17) STIPULATION and [Proposed] Order Regarding Case Coordination and Extension of Deadline for Case Schedule by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc., AstraZeneca Pharmaecuticals LP. (Joyce, Alexandra) (Entered: 10/17/2022)

Docket(#16) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,406,662 . (Silver, Daniel) (Entered: 10/05/2022)

Docket(#15) First AMENDED COMPLAINT for Patent Infringement against Ascent Pharmaceuticals Inc., Hetero Drugs Ltd.- filed by ZS Pharma, Inc., AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A-M, #2 Exhibit N-Q)(Silver, Daniel) (Entered: 10/05/2022)

Docket(#14) ORAL ORDER IT IS HEREBY ORDERED that, not later than thirty (30) days from the date of this Order, the parties shall meet and confer and file a joint proposed Scheduling Order in this action consistent with the applicable form Scheduling Order of Judge Williams, which is posted at http://www/ded/uscourts.gov (see Chambers, Judge Williams, Forms), along with a cover letter requesting the Court to enter the joint proposed Scheduling Order (if there are no disputes or other issues concerning scheduling that the Court needs to address) or to schedule the Scheduling Conference. If there are disputes or other issues the Court needs to address in the joint proposed Scheduling Order, in the cover letter, the parties shall direct the Court to the paragraph numbers in the joint proposed Scheduling Order which those appear. ORDERED by Judge Gregory B. Williams on 10/4/22. Associated Cases: 1:22-cv-01101-GBW, 1:22-cv-01055-GBW, 1:22-cv-01099-GBW (ntl) (Entered: 10/04/2022)

DocketPro Hac Vice Attorney James Y. Li for AstraZeneca Pharmaceuticals LP and ZS Pharma, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01055-GBW, 1:22-cv-01096-GBW, 1:22-cv-01099-GBW, 1:22-cv-01100-GBW, 1:22-cv-01101-GBW(mpb) (Entered: 09/21/2022)

Docket(#13) Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ascent Pharmaceuticals Inc.. (Dorsney, Kenneth) (Entered: 09/14/2022)

Docket(#12) ANSWER to #1 Complaint, by Ascent Pharmaceuticals Inc..(Dorsney, Kenneth) (Entered: 09/14/2022)

Docket(#9) DECLARATION of Service for Ascent Pharmaceuticals Inc. by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc.. (Attachments: #1 Exhibit A-B)(Joyce, Alexandra) (Entered: 08/26/2022)

Docket(#8) VAC Notice, Consent, Non-Consent, Magistrate Referral (etg) (Entered: 08/24/2022)

Docket(#7) ORAL ORDER: This case has been assigned to the District of Delaware's Vacant Judgeship ("VAC"). Detailed information relating to VAC cases may be found in the Court's Announcement of March 3, 2022 and Standing Order No. 2022-VAC-1 (March 9, 2022), which are found on the Court's website. Consistent with the foregoing Announcement and Standing Order, IT IS HEREBY ORDERED that the parties shall file the "Notice of Consent or Absence of Consent to Proceed Before a United States Magistrate Judge," being docketed along with the instant order, no later than sixty (60) days after service of the Complaint on the first defendant that is served. IT IS FURTHER ORDERED that the Notice, Consent, and Referral forms re: U.S. Magistrate Judge jurisdiction, previously docketed in this case, are VACATED. Issued by the Clerk of Court on 8/24/2022. (etg) (Entered: 08/24/2022)

DocketCase Assigned to Vacant Judgeship (2022). Please include initials of VAC after the case number on all documents filed. Associated Cases: 1:22-cv-01096-VAC, 1:22-cv-01099-VAC, 1:22-cv-01100-VAC, 1:22-cv-01101-VAC (rjb) (Entered: 08/24/2022)

Docket(#6) Summons Issued as to Ascent Pharmaceuticals Inc. on 8/22/2022; Hetero Drugs Ltd. on 8/22/2022. (Attachments: #1 Summons Issued Hetero Drugs Ltd)(smg) (Entered: 08/22/2022)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc. filed by AstraZeneca Pharmaceuticals LP, ZS Pharma, Inc. (smg) (Entered: 08/22/2022)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attached. (Attachments: #1 Patent/Trademark Report 2, #2 Patent/Trademark Report 3)(smg) (Entered: 08/22/2022)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than July 18, 2022. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/18/2025. (smg) (Entered: 08/22/2022)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) (Entered: 08/22/2022)

Docket(#1) COMPLAINT for PATENT INFRINGEMENT filed against Ascent Pharmaceuticals Inc., Hetero Drugs Ltd. ( Filing fee $ 402, receipt number ADEDC-3942066.) - filed by ZS Pharma, Inc., AstraZeneca Pharmaceuticals LP. (Attachments: #1 Exhibit A-L, #2 Civil Cover Sheet)(smg) (Entered: 08/22/2022)